PMDA drug package insert
アリピプラゾール錠3mg「ニプロ」
PMDA Prescription drug · ニプロ株式会社 · package insert Aug 5, 2026
Key facts
| Brand names | アリピプラゾール錠3mg「ニプロ」, アリピプラゾール錠6mg「ニプロ」, アリピプラゾール錠12mg「ニプロ」, アリピプラゾール散1％「ニプロ」, アリピプラゾールOD錠3mg「ニプロ」, アリピプラゾールOD錠6mg「ニプロ」, アリピプラゾールOD錠12mg「ニプロ」, アリピプラゾールOD錠24mg「ニプロ」 |
|---|---|
| Nonproprietary names | アリピプラゾール |
| Companies | 製造販売元／ニプロ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗精神病薬 |
| Therapeutic category codes | 871179 |
| YJ codes | 1179045F1112, 1179045F2119, 1179045F3115, 1179045B1072, 1179045F4111, 1179045F5118, 1179045F6114, 1179045F7110 |
| Approval numbers | 22900AMX00221, 22900AMX00222, 22900AMX00223, 22900AMX00215, 22900AMX00194, 22900AMX00195, 22900AMX00196, 22900AMX00197 |
| Package insert edition | 第4版 |
| Package insert date | Aug 5, 2026 |
| PMDA document key | 530100_1179045B1072_1 |
| PMDA company code | 530100 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: